Feto-Maternal Effects of Adding Rifampicin to Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy

Background Various pharmacological agents are used to manage intrahepatic cholestasis of pregnancy (ICP) for maternal pruritus and to lower serum bile acids in fear of adverse fetal outcomes. Ursodeoxycholic acid (UDCA) is the most widely used drug, but some patients do not respond to it. Neither UD...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumari, Anjali, Kumar, Avinash, Kumar, Manoj, Swati, Swati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Obstetrics/Gynecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840412/
https://www.ncbi.nlm.nih.gov/pubmed/36654556
http://dx.doi.org/10.7759/cureus.32509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840412/
https://www.ncbi.nlm.nih.gov/pubmed/36654556
http://dx.doi.org/10.7759/cureus.32509

Ejemplares similares